Protein Microarray
Among all the proteomics technologies, protein microarray, over the last years, has gained an increased momentum within the biomarkers discovery domain. Protein
microarray technology is an emerging field that provides a flexible platform for the characterization of thousands of proteins in a highly parallel and highâ€throughput manner. Protein microarrays are composed of two major classes. They are: analytical and functional. Additionally, tissue or cell lysates also can be fractionated and spotted on a slide to make a reverseâ€phase protein microarray. Applications of protein microarrays, especially functional protein microarrays, had increased over the past decade because the fabrication technology has matured. Protein
microarray is involved in deciphering cellular differentiation, transformation, angiogenesis, tumorigenesis, and metastasis. due to its development, it can detect alterations in protein expression levels, identify post-translational modification, mRNA events, and identify molecular networks triggered by therapeutic approaches, but also by
environmental factors. The future of
protein microarray is continuously expanding, so that profiling the
cancer signaling network, personalizing therapy and improving diagnosis and prognosis would take a breakthrough. Protein microarrays were developed due to the restrictions of using DNA microarrays for determining gene expression levels in proteomics. the quantity of mRNA within the cell often doesn't reflect the expression levels of the proteins they correspond to.
High Impact List of Articles
-
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
Sam Mathai, Paul W. Harris, Margaret A. Brimble, Alistair J. Gunn and Jian Guan
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
Sam Mathai, Paul W. Harris, Margaret A. Brimble, Alistair J. Gunn and Jian Guan
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Acute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury
Shimin Liu, Gehua Zhen, Rung-chi Li and Sylvain Dore
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Acute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury
Shimin Liu, Gehua Zhen, Rung-chi Li and Sylvain Dore
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Additional comments on the bistable network model of brain ischemia
Donald J. DeGracia
Letter to Editor: Journal of Experimental Stroke & Translational Medicine
-
Additional comments on the bistable network model of brain ischemia
Donald J. DeGracia
Letter to Editor: Journal of Experimental Stroke & Translational Medicine
-
The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischaemia studies
Amanda J. Meade, Bruno P. Meloni, Frank L. Mastaglia and Neville W. Knuckey
Review Article: Journal of Experimental Stroke & Translational Medicine
-
The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischaemia studies
Amanda J. Meade, Bruno P. Meloni, Frank L. Mastaglia and Neville W. Knuckey
Review Article: Journal of Experimental Stroke & Translational Medicine
-
A new journal to address an old problem: experimental stroke, lack of neuroprotective agents and translational medicine
Bruno P. Meloni, Kym Campbell and Neville W. Knuckey
Editorial: Journal of Experimental Stroke & Translational Medicine
-
A new journal to address an old problem: experimental stroke, lack of neuroprotective agents and translational medicine
Bruno P. Meloni, Kym Campbell and Neville W. Knuckey
Editorial: Journal of Experimental Stroke & Translational Medicine
Relevant Topics in Clinical